Project Grant R43HL170857
Award Date
9/15/24
Completion Date
9/14/25
Dollars Obligated
$296K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32607, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $1,160,157 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Liberandum Technologies, Inc. to develop and test a bidirectional synchronous flow-controlled ventilation system called "VentSafe" to improve oxygenation and ventilation in patients with Acute Respiratory Distress Syndrome (ARDS). The goal of this Phase 1 Small Business Innovation Research (SBIR) project is to overcome the limitations of...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a modern Electrical Impedance Tomography (EIT) device for monitoring children in the Intensive Care Unit (ICU). The $299,900 award to Goodlife Inventors LLC will fund efforts to (1) generate initial designs for an advanced lightweight EIT belt and (2) assess the technical feasibility of a miniaturized, easier to use EIT core device. If...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $117,750 to the Ann & Robert H Lurie Children's Hospital of Chicago to develop and validate the use of wireless biosensors and a portable capnograph device for remote patient monitoring of children on long-term invasive home mechanical ventilation. The project aims to address limitations of the hospital's current hand-collected vital sign data approach by...
This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA Program 93.837 - Cardiovascular Diseases Research aims to develop novel physiological markers of high-risk labored breathing to provide advance warning of respiratory failure. The $807,067 award to the Rector & Visitors of the University of Virginia will fund a 5-year study to quantify respiratory kinematics using a new wearable sensor technology called ARK (Analysis of Respiratory Kinematics). The...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $1,013,000 Project Grant to Endolynx Inc. to develop an Optical Sensor-Enabled Endotracheal Tube (OS-ETT). The goal of this SBIR Phase I project is to demonstrate the feasibility of the OS-ETT, which aims to reduce the risk and incidence of esophageal intubation and unintended extubation during the over 30 million intubations performed annually in the U.S. The OS-ETT...
This STTR Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $294,063 to Biomembretics, Inc. to develop and demonstrate a high-volume manufacturing technology for microfluidic oxygenators for extracorporeal membrane oxygenation (ECMO) to treat respiratory failure. The project aims to advance a bioinspired microfluidic oxygenator technology that can safely and effectively oxygenate blood, addressing limitations of the...
This $189,332 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research Program (CFDA 93.837) aims to transform the delivery of interstitial lung disease (ILD) care through remote patient monitoring and artificial intelligence-powered clinical decision support. The key products and services to be delivered under this 5-year grant include: Identifying provider and health system barriers to adopting a remote patient monitoring...
This federal Project Grant award of $371,021 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to Makani Science Inc., a small business located in Irvine, California. The goal of this 2-year award (4/9/2025 - 2/28/2027) is to develop an apnea monitoring platform capable of accurately identifying the major types of apnea of prematurity (central, obstructive, and mixed) in premature newborns. The proposed work...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc. to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions. The goal is to create a low-profile, battery-powered wireless device capable of accurately detecting and quantifying adventitious lung sounds as well as breathing abnormalities in patients with respiratory...